[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-361322-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-361322-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cd147-positive-migrasome-macropinocytosis-promotes-hcc-sorafenib-resistance-via-inducing-vasculogenic-mimicry-triggered-by-pi3kakttwist1-signaling","CD147-positive migrasome macropinocytosis promotes HCC sorafenib resistance via inducing vasculogenic mimicry triggered by PI3K/AKT/TWIST1 signaling","","Sorafenib is a widely used targeted therapy for hepatocellular carcinoma (HCC), yet resistance limits clinical benefit. Hypoxia drives vasculogenic mimicry (VM), linked to sorafenib resistance, and migrasomes (Migs) are large extracellular vesicles that can transfer functional molecules to shape malignant phenotypes. Here, hypoxia upregulates Migs release and CD147 on their surface and shows that CD147-positive hypo-Migs promote VM formation. Mechanistically, hypo-Migs enter HCC cells via LPAR6-dependent macropinocytosis, activating PI3K/AKT/TWIST1 signaling and enhancing resistance. Dual blockade of CD147-positive hypo-Migs macropinocytosis and VM improves sorafenib killing efficacy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cd147-positive-migrasome-macropinocytosis-promotes-hcc-sorafenib-resistance-via-inducing-vasculogenic-mimicry-triggered-by-pi3kakttwist1-signaling/361322/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cd147-positive-migrasome-macropinocytosis-promotes-hcc-sorafenib-resistance-via-inducing-vasculogenic-mimicry-triggered-by-pi3kakttwist1-signaling/361322.png","ImageObject",300,407,{"name":42,"@type":43},"dhado","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does hypoxia affect migrasomes and CD147 in HCC?","Question",{"text":63,"@type":64},"Hypoxia upregulates the release of migrasomes and increases CD147 expression on the migrasome surface in HCC, which is associated with sorafenib resistance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role do CD147-positive hypo-Migs play in sorafenib resistance?",{"text":68,"@type":64},"CD147-positive hypo-Migs induce vasculogenic mimicry formation, which subsequently promotes sorafenib resistance in HCC.",{"name":70,"@type":61,"acceptedAnswer":71},"Through what mechanism are hypo-Migs taken up by HCC cells and what signaling pathway is involved?",{"text":72,"@type":64},"Hypo-Migs are internalized via LPAR6-dependent macropinocytosis, and CD147-positive hypo-Migs activate the PI3K/AKT/TWIST1 signaling pathway to drive VM formation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},361322,1790716594,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nCD147-positive migrasome macropinocytosis promotes HCCsorafenib resistance via inducing vasculogenic mimicry triggered by PI3K/AKT/TWIST1 signaling  \nLuomeng Qian1, Ping Chen 2, Bo Wang1, Qing Zhang2, Yuan Guo1, Jie Cui3,4, Ran Ding 5, Hongkai Zhang6 and Sihe Zhang 1 ✉  \n© The Author(s) 2026  \n|  |  |  |\n| --- | --- | --- |\n|  | Sorafenib is a widely used targeting drug for hepatocellular carcinoma (HCC) patients; however, sorafenib resistance poses asigniﬁcant clinical challenge. Hypoxia and extracellular vesicles (EVs) induce vasculogenic mimicry (VM) which is linked to sorafenib resistance in HCC. Migrasomes (Migs), the newly discovered large EVs, foster HCC malignant phenotypes by facilitating the intercellular transfer of functional molecules. Despite these advancements, the precise mechanism by which Migs cause sorafenib resistance is still unknown. In this study, we found that hypoxia upregulates the Migs release and CD147 expression on Migs surface, which is related to sorafenib resistance in HCC. Further investigations revealed that hypoxia-induced migrasomes (hypoMigs) induce VM formation, thereby promoting sorafenib resistance in HCC. Notably, hypo-Migs are internalized into HCC cells through macropinocytosis, which depends on the expression of lysophosphatidic acid receptor 6 (LPAR6) . Mechanistically, CD147-positive (CD147+) hypo-Migs activate the PI3K/AKT/TWIST1 signaling pathway, subsequently inducing VM formation and promoting sorafenib resistance. Importantly, dual blockade of CD147+-hypo-Migs macropinocytosis and VM formation enhances the sorafenibkilling efﬁcacy to HCC. Conclusively, our ﬁndings uncover a novel sorafenib resistance mechanism induced by CD147+-hypo-Migs, |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| and highlight dual-targeting of macropinocytosis and VM as a promising strategy to overcome the sorafenib resistance in HCC. |  |  |\n|  | Cell Death and Disease (2026) 17:750 ; [https://doi.org/10.1038/s41419-026-08972-y](https://doi.org/10.1038/s41419-026-08972-y) |  |\n|  |  |  |\n\nINTRODUCTION  \nHepatocellular carcinoma (HCC) is an aggressive malignancy with limited therapeutic options. Sorafenib, a ﬁrst-line multikinase inhibitor, improves the survival of HCC patients. However, its clinical efﬁcacy is hampered by the development of sorafenib resistance (SFR) . A major cause to this resistance is that sorafenib inhibits angiogenesis, leading to a hypoxic microenvironment in HCC [1] . Although hypoxia-caused SFR is recognized [2], the underlying mechanisms have not been fully elucidated.  \nHypoxia is a well-established driver that promotes the invasion and metastasis of HCC [3–5] . It also promotes the formation of vasculogenic mimicry (VM) in HCC [6, 7] . VM is an alternative perfusion channel, independent of endothelial cells, formed by malignant cells to provide a blood supply for cancer growth and metastasis. As a vasculogenic-like network in which cancer cells undergo hypoxia and nutrient deﬁciency, VM is linked to the malignant phenotypes of HCC [8, 9] . Recently, extracellular vesicles (EVs) have been shown to promote VM formation in HCC. Antiangiogenic therapies induce the release of VEGF-enriched exosomes from endothelial cells. These exosomes promote VM formation and HCC progression [10] . circRNA-100338 is highly  \nexpressed in HCC cells and their secreted exosomes. circRNA- 100338-enriched exosomes enhance VM formation and favor HCC metastasis [11] . While these studies provide preliminary insight, the contributions of other EV subtypes, especially those secreted from hypoxic and/or metastatic HCC, to VM formation are completely unclear.  \nMigrasomes (Migs) are newly discovered large EVs that are released from migrating cells [12, 13] . Increasing evidence shows that Migs promote malignancy by orchestrating cell-cell communication, modulating the tumor m","cbCaiuVXLF7noNvW","https://ap.wps.com/l/cbCaiuVXLF7noNvW","pdf",7990705,15,"English","# Introduction\n## Sorafenib resistance and hypoxia in HCC\n## Vasculogenic mimicry as an alternative perfusion channel\n## Extracellular vesicles and migrasomes in HCC progression\n# Study focus and mechanistic rationale\n## Migrasomes, CD147, and hypoxia-induced effects","[{\"question\":\"How does hypoxia affect migrasomes and CD147 in HCC?\",\"answer\":\"Hypoxia upregulates the release of migrasomes and increases CD147 expression on the migrasome surface in HCC, which is associated with sorafenib resistance.\"},{\"question\":\"What role do CD147-positive hypo-Migs play in sorafenib resistance?\",\"answer\":\"CD147-positive hypo-Migs induce vasculogenic mimicry formation, which subsequently promotes sorafenib resistance in HCC.\"},{\"question\":\"Through what mechanism are hypo-Migs taken up by HCC cells and what signaling pathway is involved?\",\"answer\":\"Hypo-Migs are internalized via LPAR6-dependent macropinocytosis, and CD147-positive hypo-Migs activate the PI3K/AKT/TWIST1 signaling pathway to drive VM formation.\"}]","CD147-positive migrasome macropinocytosis promotes HCC sorafenib resistance via inducing vasculogenic mimicry triggered by PI3K/AKT/TWIST1 signaling | PDF",1790143941,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c62a29dcf52208cf87719a6d5754f4e1.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f661534fdd9c5e7f7145e72eec7a8ff.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b242e03984c97128f82a76768f8745de.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f46cfb10eb3d39aba9a44589b2fe5030.webp",980,1301]